BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 96 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $116,000 | +93.3% | 68,155 | +281.2% | 0.01% | +133.3% |
| Q1 2019 | $60,000 | -23.1% | 17,878 | -33.1% | 0.00% | -25.0% |
| Q4 2018 | $78,000 | -67.2% | 26,722 | -30.9% | 0.00% | -73.3% |
| Q3 2018 | $238,000 | +205.1% | 38,673 | +266.8% | 0.02% | +400.0% |
| Q2 2018 | $78,000 | -86.6% | 10,542 | -84.7% | 0.00% | -90.3% |
| Q4 2017 | $581,000 | +71.4% | 69,039 | +135.2% | 0.03% | +82.4% |
| Q3 2017 | $339,000 | – | 29,358 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EMORY UNIVERSITY | 95,215 | $1,297,000 | 1.28% |
| Baker Brothers Advisors | 4,865,647 | $66,270,000 | 0.65% |
| Eventide Asset Management | 250,000 | $3,405,000 | 0.22% |
| MCDANIEL TERRY & CO | 76,112 | $1,037,000 | 0.22% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 82,538 | $1,124,000 | 0.15% |
| QVT Financial LP | 337,923 | $4,603,000 | 0.14% |
| KENNEDY CAPITAL MANAGEMENT LLC | 478,465 | $6,517,000 | 0.11% |
| Vident Investment Advisory, LLC | 47,157 | $642,000 | 0.08% |
| Tekla Capital Management LLC | 60,000 | $817,000 | 0.04% |
| First Eagle Investment Management, LLC | 775,254 | $10,559,000 | 0.03% |